9-MESITYL-10-METHYLACRIDIN-10-IUM TETRAFLUOROBORATE, 95%, 5g

1,2-INDANDIONE 2-OXIME, 95.0%, 1g

6-Bromo-quinoline-2-carbonitrile, 95.0%, 1g

2-(4-FLUOROPHENYL)-6,7-DIHYDROPYRAZOLO[1,5-A]PYRAZIN-4(5H)-ONE, 95.0%, 1g

N-(2-(Diethylamino)ethyl)-5-formyl-2,4-dimethyl-1H-pyrrole-3-carboxamide, 95.0%, 10g

1-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-5-carbaldehyde, 97.0%, 250mg

Colonnes de garde HPLC (analytiques) Pyramide NUCLEODUR® C18, 3 pièce(s)

N-Boc-2-{2-[2-(2-amino-ethoxy)-ethoxy]-ethoxy} ethylamine, 98.0%, 250mg

(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid, 97.0%, 25g

5-Ethynylpyridin-2-ol, 95.0%, 5g

3,7-Dichloro-10,11-dihydro-5H-dibenzo[b,f]azepine, 97%, 250mg

2-PHENYL-9H-FLUOREN-9-ONE, 95.0%, 100mg

Cholesterol n-Octanoate>95.0%(GC)5g